High-fidelity Cas9-mediated targeting of KRAS driver mutations restrains lung cancer in preclinical models

Juan Carlos Álvarez-Pérez(Universidad de Granada), Pedro P. Medina(Universidad de Granada)
Nature Communications
September 1, 2025
Cited by 5


Related Papers